CRMD
CorMedix Inc
7.40$
+0.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 0.00 | 0.00 | 0.00 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.74 | 3.88 | |
| 6.18 | – | – | 0.00 | 0.00 | 0.07 | 0.10 | 0.05 | 0.05 | 0.01 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.05 | 0.45 | |
| -6.18 | – | – | 0.00 | 0.00 | -0.07 | -0.06 | -0.02 | -0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.68 | 3.43 | |
| 18.30 | 28.53 | 2.90 | 1.80 | 0.52 | 0.44 | 0.31 | 1.00 | 2.07 | 2.22 | 1.06 | 0.46 | 0.47 | 0.35 | 0.27 | 0.26 | 0.07 | 0.24 | |
| 28.53 | 6.81 | 1.59 | 1.38 | 0.81 | 1.26 | 1.71 | 1.64 | 1.17 | 0.78 | 0.45 | 0.41 | 0.49 | 0.43 | 0.50 | 0.35 | 0.51 | 0.85 | |
| 22.41 | 35.34 | 4.49 | 3.18 | 1.33 | 1.71 | 2.02 | 2.64 | 3.24 | 3.00 | 1.51 | 0.87 | 0.95 | 0.78 | 0.76 | 0.96 | 1.06 | 1.56 | |
| -28.59 | -35.34 | -4.49 | -3.18 | -1.33 | -1.78 | -2.08 | -2.66 | -3.26 | -2.99 | -1.51 | -0.87 | -0.95 | -0.78 | -0.76 | -0.96 | -0.38 | 1.87 | |
| 24.98 | 12.07 | 1.63 | 0.01 | 0.17 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | |
| -53.42 | -47.40 | -5.90 | -3.16 | -1.50 | -3.30 | -4.77 | -2.90 | -3.25 | -2.99 | -1.51 | -0.47 | -0.95 | -0.78 | -0.75 | -0.91 | -0.33 | 1.87 | |
| – | 0.01 | -0.15 | -0.22 | 0.00 | 0.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 | -0.18 | -0.03 | -0.01 | 0.00 | -0.02 | -0.16 | |
| -53.42 | -47.40 | -5.76 | -2.94 | -1.50 | -3.30 | -4.77 | -2.90 | -3.25 | -2.99 | -1.51 | -0.68 | -0.77 | -0.75 | -0.74 | -0.91 | -0.30 | 2.03 | |
| -22.26 | -35.27 | -4.47 | -3.15 | -1.33 | -2.78 | -4.77 | -2.90 | -3.24 | -2.99 | -1.50 | -0.87 | -0.95 | -0.78 | -0.75 | -0.91 | -0.32 | 2.09 |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.